SOD1 and Parkinson disease: It is also notable that misfolded SOD1 immunoreactive to C4F6 and UβB was observed, albeit with less amount, in CSF of a subset of patients with Parkinson’s disease (PD) and progressive supranuclear palsy (PSP).